Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Foot-and-mouth disease virus capsid protein VP4 is an internal structural protein essential for proper assembly and function of the FMDV icosahedral capsid[1][4]. The protein is unique among the four FMDV capsid proteins in being myristoylated and entirely enclosed within the mature virion, rather than surface-exposed like VP1-VP3[1][2]. VP4 plays critical roles in capsid stability, receptor binding, and the antigenic properties of the virus; mutant capsids lacking VP4 show significantly reduced capacity to bind integrin receptors and are antigenically distinct from wild-type virions[1]. During viral entry, VP4 is released along with the viral RNA when the capsid dissociates in the acidic environment of the endosome[2]. Rather than being a therapeutic target itself, VP4 is important as a structural determinant that influences vaccine efficacy and viral pathogenesis, with understanding of VP4 function potentially informing development of improved FMDV vaccines and antiviral strategies.
Not applicable—VP4 is a viral component rather than a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Foot-and-Mouth Disease Virus Capsid Protein VP4 (VP4).